Skip to main content

Table 1 Clinical characteristics of 86 patients with newly diagnosed AML and expression of miR-96

From: Prognostic value of miR-96 in patients with acute myeloid leukemia

Characteristics

Cases

miRc96 expression level

x 2

p

Low expression

High expression

Sex

Male

42

28

14

0.374

0.541

 

Female

44

32

12

  

Age

<60

64

46

18

0.527

0.468

 

≥60

22

14

8

  

WBC

<10

26

11

15

13.323

0.000*

 

≥10

60

49

11

  

HGB

<80

54

42

12

4.415

0.036*

 

≥80

32

18

14

  

PLT

<50

48

38

10

4.550

0.033*

 

≥50

38

22

16

  

Blast in BM

<50%

37

21

16

5.212

0.022*

 

≥50%

49

39

10

  

FAB subtype

M1/M2

35

25

10

0.791

0.673

 

M4/M5

47

33

14

  
 

Other

4

2

2

  

Cytogenitics

Favorable

12

7

5

0.516

0.776

 

Intermediate

39

26

13

  
 

Unfavorable

14

10

4

  

Complete Remission

Y

42

28

14

1.551

0.213

 

N

30

24

6

  
  1. *P<0.05.